Cargando…
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
BACKGROUND: Glioblastoma is an incurable disease with a poor prognosis. For caregivers of people with glioblastoma, the burden of care can be high. Patients often present with different clinical characteristics, which may impact caregiver burden in different ways. This study aimed to evaluate associ...
Autores principales: | Au, Trang H., Willis, Connor, Reblin, Maija, Peters, Katherine B., Nghiemphu, Phioanh Leia, Taylor, Jennie W., Colman, Howard, Cohen, Adam L., Ormond, D. Ryan, Chakravarti, Arnab, Willmarth, Nicole, Menon, Jyothi, Ma, Junjie, Bauer, Hillevi, Watanabe, Alexandre H., Ulrich, Cornelia M., Singh, Prianka, Marshall, Alexander, Korytowsky, Beata, Stenehjem, David, Brixner, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727395/ https://www.ncbi.nlm.nih.gov/pubmed/34510238 http://dx.doi.org/10.1007/s00520-021-06514-0 |
Ejemplares similares
-
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
por: Au, Trang H., et al.
Publicado: (2021) -
Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center
por: Stenehjem, David D., et al.
Publicado: (2019) -
Impact of a genetic counseling requirement prior to genetic testing
por: Stenehjem, David D., et al.
Publicado: (2018) -
Tumor mutational burden in lung cancer: a systematic literature review
por: Willis, Connor, et al.
Publicado: (2019) -
A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas
por: Nghiemphu, Phioanh Leia, et al.
Publicado: (2012)